NRC EBITDA | NRC Health

NRC Health (NRC) EBITDA

2026-06-30: Basis Reported; EBITDA (m); Operating income -$3.24M; Depreciation and amortization (m).
2026-03-31: Basis Reported; EBITDA (m); Operating income $5.57M; Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA (m); Operating income $7.74M; Depreciation and amortization (m).
2025-06-30: Basis Reported; EBITDA (m); Operating income $1.59M; Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history: 2009-12-31 to 2015-09-30
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	(m)	-$3.24M	(m)	$35.39M	(m)	$1.32M*	$1.39M*	(m)	(m)	$22.95M	-$1.25M
2026-03-31	Reported	(m)	$5.57M	(m)	$34.80M	(m)	$1.83M	$7.18M	(m)	(m)	$13.42M	$1.16M
2025-09-30	Reported	(m)	$7.74M	(m)	$34.61M	(m)	$3.59M*	$13.76M*	(m)	(m)	$12.27M	$2.15M
2025-06-30	Reported	(m)	$1.59M	(m)	$34.04M	(m)	$3.01M*	-$1.14M*	(m)	(m)	$17.73M	$687.00K
2025-03-31	Reported	(m)	$8.60M	(m)	$33.55M	(m)	$2.99M	$6.65M	(m)	(m)	$10.36M	$1.94M
2024-09-30	Reported	(m)	$7.98M	(m)	$35.82M	(m)	$1.60M*	$9.42M*	(m)	(m)	$10.99M	$1.61M
2024-06-30	Reported	(m)	$8.87M	(m)	$35.02M	(m)	$5.27M*	$6.79M*	(m)	(m)	$11.22M	$2.15M
2024-03-31	Reported	(m)	$8.76M	(m)	$35.31M	(m)	$4.14M	$12.04M	(m)	(m)	$11.25M	$1.83M
2023-09-30	Reported	(m)	$9.96M	(m)	$37.95M	(m)	$4.47M*	$9.82M*	(m)	(m)	$11.80M	$2.16M
2023-06-30	Reported	(m)	$9.37M	(m)	$36.16M	(m)	$4.34M*	$8.84M*	(m)	(m)	$11.97M	$2.17M
2023-03-31	Reported	(m)	$9.02M	(m)	$36.47M	(m)	$3.20M	$7.75M	(m)	(m)	$11.78M	$2.05M
2022-09-30	Reported	(m)	$11.11M	(m)	$37.69M	(m)	$3.98M*	$10.05M*	(m)	(m)	$10.76M	$2.55M
2022-06-30	Reported	(m)	$11.50M	(m)	$37.29M	(m)	$1.34M*	$9.82M*	(m)	(m)	$10.75M	$2.74M
2022-03-31	Reported	(m)	$11.70M	(m)	$38.44M	(m)	$2.54M	$8.29M	(m)	(m)	$10.65M	$2.89M
2021-09-30	Reported	(m)	$13.14M	(m)	$37.77M	(m)	$992.00K*	$8.70M*	(m)	(m)	$9.52M	$2.97M
2021-06-30	Reported	(m)	$12.24M	(m)	$36.42M	(m)	$1.57M*	$11.16M*	(m)	(m)	$10.02M	$2.95M
2021-03-31	Reported	(m)	$12.02M	(m)	$35.46M	(m)	$1.24M	$14.41M	(m)	(m)	$9.52M	$2.38M
2020-09-30	Reported	(m)	$12.02M	(m)	$33.48M	(m)	$1.01M*	$10.52M*	(m)	(m)	$7.95M	$2.09M
2020-06-30	Reported	(m)	$9.28M	(m)	$31.17M	(m)	$837.00K*	$8.38M*	(m)	(m)	$8.85M	$842.00K
2020-03-31	Reported	(m)	$11.19M	(m)	$33.86M	(m)	$590.00K	$5.52M	(m)	(m)	$8.75M	-$385.00K
2019-09-30	Reported	(m)	$10.22M	(m)	$32.47M	(m)	$1.15M*	$12.87M*	(m)	(m)	$8.71M	$1.69M
2019-06-30	Reported	(m)	$10.15M	(m)	$31.41M	(m)	$1.15M*	$8.81M*	(m)	(m)	$8.32M	$2.09M
2019-03-31	Reported	(m)	$10.70M	(m)	$31.48M	(m)	$1.13M	$7.30M	(m)	(m)	$7.71M	$1.66M
2018-09-30	Reported	(m)	$9.17M	(m)	(m)	(m)	$2.08M*	$7.54M*	(m)	(m)	$7.68M	$1.39M
2018-06-30	Reported	(m)	$7.76M	(m)	(m)	(m)	$1.48M*	$10.16M*	(m)	(m)	$7.94M	-$129.00K
2018-03-31	Reported	(m)	$8.96M	(m)	(m)	(m)	$1.30M	$8.23M	(m)	(m)	$7.87M	$1.66M
2017-09-30	Reported	(m)	$7.12M	(m)	(m)	(m)	$957.00K*	$10.86M*	(m)	(m)	$8.43M	$3.02M
2017-06-30	Reported	(m)	$8.45M	(m)	(m)	(m)	$965.00K*	$2.48M*	(m)	(m)	$6.91M	$2.72M
2017-03-31	Reported	(m)	$9.98M	(m)	(m)	(m)	$1.43M	$8.14M	(m)	(m)	$6.69M	$3.46M
2016-09-30	Reported	(m)	$7.34M	(m)	(m)	(m)	$849.00K*	$6.79M*	(m)	(m)	$7.14M	$2.58M
2016-06-30	Reported	(m)	$7.02M	(m)	(m)	(m)	$1.13M*	$6.86M*	(m)	(m)	$7.27M	$2.48M
2016-03-31	Reported	(m)	$8.01M	(m)	(m)	(m)	$1.08M	$4.37M	(m)	(m)	$7.36M	$2.50M
2015-09-30	Reported	$7.62M	(m)	(m)	(m)	30.18%	$575.00K*	$5.54M*	(m)	(m)	$6.62M	$2.35M
2015-06-30	Reported	$7.39M	(m)	(m)	(m)	30.20%	$875.00K*	$7.66M*	(m)	(m)	$6.64M	$2.26M
2015-03-31	Reported	$6.84M	(m)	(m)	(m)	26.05%	$757.00K	$1.58M	(m)	(m)	$7.63M	$2.30M
2014-12-31	Reported	$7.41M	(m)	(m)	(m)	29.50%	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Reported	$8.11M	(m)	(m)	(m)	34.24%	$675.00K*	$9.24M*	(m)	(m)	$5.80M	$2.56M
2014-06-30	Reported	$7.24M	(m)	(m)	(m)	30.18%	$820.00K*	$6.21M*	(m)	(m)	$5.98M	$2.21M
2014-03-31	Reported	$9.34M	(m)	(m)	(m)	35.86%	$605.00K	$5.16M	(m)	(m)	$6.37M	$2.89M
2013-12-31	Reported	$6.97M	(m)	(m)	(m)	30.41%	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Reported	$6.94M	(m)	(m)	(m)	30.95%	$595.00K*	$9.37M*	(m)	(m)	$6.02M	$2.13M
2013-06-30	Reported	$6.47M	(m)	(m)	(m)	28.92%	$550.00K*	$2.87M*	(m)	(m)	$6.39M	$2.03M
2013-03-31	Reported	$8.17M	(m)	(m)	(m)	32.79%	$416.00K	$3.10M	(m)	(m)	$6.49M	$2.66M
2012-12-31	Reported	$6.87M	(m)	(m)	(m)	31.22%	(m)	(m)	(m)	(m)	(m)	(m)
2012-09-30	Reported	$6.8M	(m)	(m)	(m)	31.78%	$606.00K*	$5.79M*	(m)	(m)	$5.82M	$1.92M
2012-06-30	Reported	$6.43M	(m)	(m)	(m)	31.17%	$651.00K*	$5.72M*	(m)	(m)	$5.57M	$1.17M
2012-03-31	Reported	$7.33M	(m)	(m)	(m)	32.69%	$633.00K	$2.08M	(m)	(m)	$6.15M	$2.08M
2011-12-31	Reported	$6.29M	(m)	(m)	(m)	32.89%	(m)	(m)	(m)	(m)	(m)	(m)
2011-09-30	Reported	$5.51M	(m)	(m)	(m)	29.68%	$969.00K*	$6.11M*	(m)	(m)	$5.57M	$1.47M
2011-06-30	Reported	$5.07M	(m)	(m)	(m)	27.66%	$547.00K*	$4.38M*	(m)	(m)	$5.99M	$1.36M
2011-03-31	Reported	$6.94M	(m)	(m)	(m)	35.08%	$760.00K	$3.88M	(m)	(m)	$6.09M	$2.05M
2010-12-31	Reported	$3.68M	(m)	(m)	(m)	23.18%	(m)	(m)	(m)	(m)	(m)	(m)
2010-09-30	Reported	$4.72M	(m)	(m)	(m)	29.48%	$509.00K*	$3.20M*	(m)	(m)	$5.25M	$1.19M
2010-06-30	Reported	$3.72M	(m)	(m)	(m)	26.29%	(m)	(m)	(m)	(m)	$4.54M	$956.00K

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	(m)	$22.59M	(m)	$137.39M	(m)	$10.71M	$26.45M	(m)	(m)	$54.80M	$6.25M
2024-12-31	Reported	(m)	$35.19M	(m)	$143.06M	(m)	$15.45M	$34.63M	(m)	(m)	$44.91M	$7.91M
2023-12-31	Reported	(m)	$40.05M	(m)	$148.58M	(m)	$15.78M	$38.11M	(m)	(m)	$46.62M	$8.99M
2022-12-31	Reported	(m)	$46.54M	(m)	$151.57M	(m)	$9.84M	$36.27M	(m)	(m)	$42.70M	$11.02M
2021-12-31	Reported	(m)	$50.27M	(m)	$147.95M	(m)	$5.51M	$46.34M	(m)	(m)	$38.96M	$11.15M
2020-12-31	Reported	(m)	$42.68M	(m)	$133.28M	(m)	$3.98M	$40.64M	(m)	(m)	$34.44M	$4.21M
2019-12-31	Reported	(m)	$43.03M	(m)	$127.98M	(m)	$4.66M	$40.92M	(m)	(m)	$32.97M	$8.11M
2018-12-31	Reported	(m)	$35.27M	(m)	$119.69M	(m)	$5.97M	$39.85M	(m)	(m)	$31.37M	$4.66M
2017-12-31	Reported	(m)	$34.22M	(m)	$117.56M	(m)	$4.57M	$28.09M	(m)	(m)	$29.69M	$11.34M
2016-12-31	Reported	(m)	$31.20M	(m)	(m)	(m)	$3.97M	$26.84M	(m)	(m)	$28.39M	$10.84M
2015-12-31	Reported	(m)	$26.45M	(m)	(m)	(m)	$2.94M	$21.89M	(m)	(m)	$27.18M	$9.75M
2014-12-31	Reported	$32.1M	(m)	(m)	(m)	32.48%	$2.49M	$26.20M	(m)	(m)	$25.02M	$9.94M
2013-12-31	Reported	$28.54M	(m)	(m)	(m)	30.82%	$2.19M	$19.32M	(m)	(m)	$25.21M	$9.00M
2012-12-31	Reported	$27.42M	(m)	(m)	(m)	31.73%	$2.35M	$19.13M	(m)	(m)	$23.54M	$7.14M
2011-12-31	Reported	$23.8M	(m)	(m)	(m)	31.41%	$2.81M	$18.48M	(m)	(m)	$23.30M	$6.60M
2010-12-31	Reported	$18.56M	(m)	(m)	(m)	29.28%	$1.54M	$14.60M	(m)	(m)	$20.20M	$4.82M
2009-12-31	Reported	$17.53M	(m)	(m)	(m)	30.38%	$2.91M	$13.67M	(m)	(m)	$16.02M	$4.63M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
OmniAb, Inc. (OABI)	United States	$0.698B	-8.05
MAXCYTE, INC. (MXCT)	United States	$0.124B	-3.68
bioAffinity Technologies, Inc. (BIAF)	United States	$0.063B
OneMedNet Corp (ONMD)		$0.042B
iSpecimen Inc. (ISPC)	United States	$0.003B
FOXO TECHNOLOGIES INC. (FOXO)	United States	$0.000B	-277.71
Absci Corp (ABSI)	United States	$1.775B	-14.92
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)	United States	$14.060B	-43.97
Medpace Holdings, Inc. (MEDP)	United States	$17.316B	30.09
INCYTE CORP (INCY)	United States	$24.855B	13.14